MedTrace Logo

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

NCT00563862 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 465

Last updated 2011-06-16

No results posted yet for this study

Summary

To test the therapeutic ratio of accelerated radiotherapy and/or chemotherapy on locally advanced nasopharyngeal carcinoma.

Conditions

  • Nasopharyngeal Neoplasms
  • Carcinoma, Squamous Cell

Interventions

PROCEDURE

Conventional RT

PROCEDURE

Accelerated RT

DRUG

Cisplatin

DRUG

5-fluorouracil

Sponsors & Collaborators

  • The Hong Kong Nasopharyngeal Cancer Study Group

    collaborator UNKNOWN

  • Hospital Authority, Hong Kong

    lead OTHER_GOV

Principal Investigators

  • Anne WM Lee, Dr · Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-07-31
Completion
2007-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00563862 on ClinicalTrials.gov